GlaxoSmithKline has defeated claims by the ACCC that revised packaging for its now-discontinued pain killer Osteo Gel misled consumers. The drug maker will face penalties for earlier violations it admitted to, but the court hinted the damages will be nowhere near the $6 million competitor Reckitt Benckiser faced in a similar case.
Microsoft can’t get ‘free hand’ to change case in re-trial of IP spat, judge says
Jack de Belin weighs appeal as judge upholds NRL’s stand-down rule
Court approves investors’ takeover of Angas Securities
Lecturer sacked over swastika drops political opinion claim against University of Sydney
Ex-partner files sex discrimination lawsuit after leaving national firm
Over protests, judge sets trial date in ASIC case against Tennis Australia duo
BASF sues to stamp out alleged infringement of termite control patent
Facebook, Instagram to fight misuse of market power case by social media startup
Pacific National’s undertaking better for rail competition, says judge in tossing ACCC case
Potential new entrants to a major freight terminal in Queensland will be “better protected” by a last-minute promise by the terminal’s hopeful owner, Pacific National, than if the ACCC had succeeded in blocking the rail operator’s proposed $205 million acquisition, according to the judge who dismissed the competition watchdog’s case.